IP Library › Granted Patent US 9,617,582
Granted Patent B2
US 9,617,582 · App. 14/017,764 · Granted Apr 11, 2017

Human exhaled aerosol droplet biomarker system and method

Inventors: Donald K. Milton (University Park, MD); Ian M. White (Ellicott City, MD)
Assignee: University of Maryland College Park
C12Q1/6804G01N33/54366G01N33/6863G01N2333/52G01N2333/525G01N2333/545G01N2333/5418G01N2333/5421G01N2333/5437G01N2333/57G01N2800/122G01N2800/26
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,617,582
App. No.
14/017,764
Granted
Apr 11, 2017
Kind
B2
Abstract

A system and method for detecting a biomarker in exhaled breath condensate nanodroplets comprises noninvasively collecting exhaled breath condensate nanodroplets of a subject, and analyzing said nanodroplets utilizing immuno-quantitative polymerase chain reaction to detect one or more target biomarkers.

Claims (11)

1. A system for detecting biomarkers in exhaled breath nanodroplets, comprising:

a collection device configured to noninvasively collect exhaled breath condensate nanodroplets from a subject by impacting said nanodroplets into a liquid medium, said collection device comprising an optical particle counter configured to determine number and size distribution of said nanodroplets; and

immuno-quantitative polymerase chain reaction (IqPCR) assay for detecting one or more target biomarkers in said nanodroplets.

2. The system of claim 1 , wherein said IqPCR assay comprises a microbead having an antibody immobilized thereon, wherein said antibody binds to a particular one of said target biomarkers.

3. The system of claim 1 , wherein said IqPCR exhibits at least a 10-fold increase in sensitivity in detection of said target biomarkers as compared to enzyme-linked immuno-sorbent assay (ELISA).

4. The system of claim 3 , wherein said IqPCR exhibits at least a 1000-fold increase in sensitivity in detection of said target biomarkers as compared to enzyme-linked immuno-sorbent assay (ELISA).

5. The system of claim 1 , wherein said biomarkers are associated with a respiratory disease, disorder or infection.

6. The system of claim 1 , wherein said biomarkers comprise cytokines.

7. The system of claim 6 , wherein said biomarkers are selected from the group consisting of IFN-gamma, IL-1 beta, IL-7, IL-8, IL-13, and TNF-alpha.

8. The system of claim 1 , wherein said IqPCR assay comprises a plurality of microbead-antibody complexes for simultaneous detection of multiple target biomarkers.

9. The system of claim 1 , wherein at least one of said target biomarkers is associated with a respiratory disease, disorder or infection.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 26, 2013
From: MILTON, DONALD K.; WHITE, IAN M.
To: UNIVERSITY OF MARYLAND COLLEGE PARK
Reel/Frame 031676/0565 →
Continuity (3)
Provisional Application 61696641 · Sep 4, 2012
Provisional Application 61726423 · Nov 14, 2012
Related Publication 20140065602A1 · Mar 6, 2014